Value of serum human epidermal growth factor receptor 2 (HER2)/ neu testing for early prediction of response to HER2/neu-directed therapies is still an open one and deserves further study in large prospective trials

Suhail M. Ali; Kim Leitzel; Allan Lipton; Walter P. Carney; Wolfgang J. Köstler

doi:10.1200/JCO.2009.23.4674

Value of serum human epidermal growth factor receptor 2 (HER2)/ neu testing for early prediction of response to HER2/neu-directed therapies is still an open one and deserves further study in large prospective trials

Suhail M. Ali, Kim Leitzel, Allan Lipton, Walter P. Carney, Wolfgang J. Köstler

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e273
Journal	Journal of Clinical Oncology
Volume	27
Issue number	36
DOIs	https://doi.org/10.1200/JCO.2009.23.4674
State	Published - Dec 20 2009

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

Access to Document

10.1200/JCO.2009.23.4674

Cite this

Ali, S. M., Leitzel, K., Lipton, A., Carney, W. P., & Köstler, W. J. (2009). Value of serum human epidermal growth factor receptor 2 (HER2)/ neu testing for early prediction of response to HER2/neu-directed therapies is still an open one and deserves further study in large prospective trials. Journal of Clinical Oncology, 27(36), e273. https://doi.org/10.1200/JCO.2009.23.4674

@article{fb101fd8c9d14e7aa88857c96545399e,

title = "Value of serum human epidermal growth factor receptor 2 (HER2)/ neu testing for early prediction of response to HER2/neu-directed therapies is still an open one and deserves further study in large prospective trials",

author = "Ali, {Suhail M.} and Kim Leitzel and Allan Lipton and Carney, {Walter P.} and K{\"o}stler, {Wolfgang J.}",

year = "2009",

month = dec,

day = "20",

doi = "10.1200/JCO.2009.23.4674",

language = "English (US)",

volume = "27",

pages = "e273",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "36",

}

Ali, SM, Leitzel, K, Lipton, A, Carney, WP & Köstler, WJ 2009, 'Value of serum human epidermal growth factor receptor 2 (HER2)/ neu testing for early prediction of response to HER2/neu-directed therapies is still an open one and deserves further study in large prospective trials', Journal of Clinical Oncology, vol. 27, no. 36, pp. e273. https://doi.org/10.1200/JCO.2009.23.4674

Value of serum human epidermal growth factor receptor 2 (HER2)/ neu testing for early prediction of response to HER2/neu-directed therapies is still an open one and deserves further study in large prospective trials. / Ali, Suhail M.; Leitzel, Kim; Lipton, Allan et al.
In: Journal of Clinical Oncology, Vol. 27, No. 36, 20.12.2009, p. e273.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Value of serum human epidermal growth factor receptor 2 (HER2)/ neu testing for early prediction of response to HER2/neu-directed therapies is still an open one and deserves further study in large prospective trials

AU - Ali, Suhail M.

AU - Leitzel, Kim

AU - Lipton, Allan

AU - Carney, Walter P.

AU - Köstler, Wolfgang J.

PY - 2009/12/20

Y1 - 2009/12/20

UR - http://www.scopus.com/inward/record.url?scp=74949093236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74949093236&partnerID=8YFLogxK

U2 - 10.1200/JCO.2009.23.4674

DO - 10.1200/JCO.2009.23.4674

M3 - Letter

C2 - 19917836

AN - SCOPUS:74949093236

SN - 0732-183X

VL - 27

SP - e273

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 36

ER -

Value of serum human epidermal growth factor receptor 2 (HER2)/ neu testing for early prediction of response to HER2/neu-directed therapies is still an open one and deserves further study in large prospective trials

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this